References
- Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham study. JAMA. 1979; 241: 2035–8
- Mølstad P, Nustad M. Acute myocardial infarction in diabetic patients. Acta Med Scand. 1987; 222: 433–7
- Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: Pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992; 20: 736–44
- Niles NW, Grath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. for the Nothern New England Cardiovascular Disease Study Group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: Results of a large prospective study. J Am Coll Cardiol. 2001; 37: 1008–15
- Mølstad, P. Coronary artery heart disease: Significance of initial treatment strategy on subsequent long term survival. A comparison of percutaneous coronary intervention and coronary artery bypass grafting in a single centre. Scand Cardiovasc J. 2007, (accepted for publication).
- The BARI Investigators. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000; 35: 1122–9
- King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty versus surgery trial (EAST). J Am Coll Cardiol. 2000; 35: 1116–21
- Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: Comparison with the randomized trial; BARI Investigators. Circulation. 2000; 101: 2795–802
- Detre KM, Guo P, Holubkov R, Califf RM, Sopko G, Bach R, et al. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999; 99: 633–40
- Cox D. Regression models and life tables. J R Stat Soc B. 1972; 34: 187–220
- Hosmer DW, Lemeshow S. Regression modeling of time to event data. John Wiley & sons Inc, New York 1999
- Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229–34
- Brener SJ, Lytle BW, Casserly IP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary disease and high-risk features. Circulation. 2004; 109: 2290–5
- Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg. 2006; 82: 1420–9
- Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stentimplantation. New Engl J Med. 2005; 352: 2174–83
- Will JC, Galuska DA, Ford ES, Moktad A, Calle EE. Cigarette smoking and diabetes mellitus: Evidence of a positive association from a large prospective cohort study. Int J Epidemiol. 2001; 30: 540–6
- Solberg LI, Desai JR, O'Connor PJ, Devlin HM. Diabetic patients who smoke: Are they different?. Ann Fam Med. 2004; 2: 26–32
- Al-Delaimy WK, Speizer FE, Willett WC, Hu FB, Manson JE. Smoking and mortality among women with type 2 diabetes. Diabetes Care. 2001; 24: 2043–8
- Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care. 1999; 22: 1887–98
- Moy CS, LaPorte RE, Dorman JS, Songer TJ, Orchard TJ, Kuller LH, et al. Insulin-dependant diabetes mellitus mortality. The risk of cigarette smoking. Circulation. 1990; 82: 37–43
- Timmer JR, Breeman A, Ottervanger JP, de Kluiver EP, Boonstra PW, Zijlstra F. Long-term clinical outcome of patients with diabetes proposed for coronary revascularisation. Neth J Med. 2006; 64: 296–301